Table 3.
Body weight, BCS, and caloric consumption by obesification group and time point (study week) during weight loss.
| Group | Baseline | 1 week | 4 weeks | 8 weeks | 12 weeks1 |
|---|---|---|---|---|---|
| Body weight (kg) | |||||
| ObN | 16.4 ± 0.7b,# | 16.0 ± 0.8b,c,#,$ | 15.0 ± 1.1b,$ | 13.7 ± 1.3b,% | 12.9 ± 1.5b,% |
| ObP | 17.2 ± 1.4b,# | 17.0 ± 1.1c,# | 16.8 ± 0.9c,# | 15.9 ± 0.4c,# | 16.0 ± 0.4c,# |
| WLD | 16.3 ± 1.4b,# | 15.3 ± 1.4b,#,$ | 14.7 ± 1.0b,$,% | 13.9 ± 1.0b,% | 12.4 ± 1.0a,b,∧ |
| IBW | 11.2 ± 0.8a,# | 11.3 ± 0.7a,# | 12.2 ± 0.7a,#,$ | 12.5 ± 0.8a,$ | 11.8 ± 0.9a,#,$ |
| BCS (9-point) | |||||
| ObN | 8.8 ± 0.4b,# | 8.8 ± 0.4b,# | 8.0 ± 0.7b,# | 7.4 ± 0.9b,# | 6.4 ± 0.9b,$ |
| ObP | 8.2 ± 0.8b,# | 8.0 ± 1.0b,# | 8.0 ± 0.7b,# | 8.0 ± 1.4b,# | 7.4 ± 0.9b,# |
| WLD | 8.4 ± 1.3b,# | 8.0 ± 1.2b,#,$ | 7.8 ± 1.1b,#,$ | 6.8 ± 1.3b,$ | 5.3 ± 1.0a,% |
| IBW | 4.3 ± 0.8a,# | 4.5 ± 0.5a,# | 5.0 ± 0.0a,# | 5.0 ± 0.0a,# | 4.2 ± 0.4a,# |
| Calories offered (kcal/BWkg0.75) | |||||
| ObN | 75.0 ± 17.2a,# | 79.6 ± 16.1a,#,$ | 83.6 ± 14.9a,#,$ | 90.8 ± 11.3a,#,$ | 101.3 ± 12.7a,$ |
| ObP | 141.4 ± 41.2b,# | 128.7 ± 19.2b,# | 129.1 ± 18.6b,# | 134.0 ± 16.6b,c,# | 134.1 ± 17.3b,# |
| WLD | 123.4 ± 58.9b,# | 111.5 ± 40.2b,# | 114.3 ± 38.4b,# | 120.7 ± 38.5b,# | 117.5 ± 31.1b,# |
| IBW | 215.2 ± 42.6c,# | 207.6 ± 40.2c,# | 179.7 ± 32.7c,#,$ | 156.5 ± 31.6c,$,% | 139.8 ± 38.9b,% |
| Calories consumed (kcal/BWkg0.75) | |||||
| ObN | 63.1 ± 16.2a,# | 79.6 ± 16.1a,#,$ | 83.6 ± 14.9a,#,$ | 90.8 ± 11.3a,#,$ | 101.3 ± 12.7a,$ |
| ObP | 88.6 ± 17.2a,# | 120.3 ± 23.9b,$ | 128.1 ± 20.2b,$ | 134.0 ± 16.6b,c,$ | 134.1 ± 17.3a,b,$ |
| WLD | 87.2 ± 25.8a,# | 87.7 ± 16.7a,# | 113.7 ± 37.7a,b,#,$ | 120.7 ± 38.5a,b,$ | 112.7 ± 22.8a,b,$ |
| IBW | 215.1 ± 42.6b,# | 207.6 ± 40.2c,# | 179.7 ± 32.7c,#,$ | 156.5 ± 31.6c,$,% | 139.7 ± 38.9b,% |
Numerical data presented as mean ± standard deviation.
ObN, obese nutraceutical group; ObP, obese placebo group; WLD, weight loss diet group; IBW, ideal body weight group.
Except where otherwise indicated, n = 5 for obesification groups (ObN, ObP, WLD) and n = 6 for group IBW.
WLD in this column determined from 4 dogs, because 1 dog reached ideal weight and ended treatment at 8 weeks.
Within a column, values with different superscript letters differ significantly (p < 0.05).
Across columns, values with different superscript symbols differ significantly (p < 0.05).